NCT03172884 2021-04-28
Study of Copanlisib in Hepatic or Renal Impairment
Bayer
Phase 1 Completed
Bayer
National Institutes of Health Clinical Center (CC)
Debiopharm International SA
Janssen Research & Development, LLC
ANRS, Emerging Infectious Diseases